1671. Activity of Imipenem/Relebactam and Comparators Against Gram-Negative MDR and DTR Pathogens from Patients with Respiratory and Bloodstream Infections – SMART United States 2018-2020

BACKGROUND: Gram-negative pathogens with multidrug resistance (MDR) or difficult-to-treat resistance (DTR) are increasingly common, resulting in limited treatment options. These resistant pathogens are often isolated from the respiratory tract or bloodstream and can result in significant patient mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Hackel, Meredith, Siddiqui, Fakhar, Bauer, Karri A, DeRyke, Charles A, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752767/
http://dx.doi.org/10.1093/ofid/ofac492.1301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752767/
http://dx.doi.org/10.1093/ofid/ofac492.1301

Ejemplares similares